198 related articles for article (PubMed ID: 1657203)
1. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
Babbar A; Kashyap R; Chauhan UP
J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
Chauhan UP; Babbar A; Kashyap R; Prakash R
Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
[TBL] [Abstract][Full Text] [Related]
3. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
[TBL] [Abstract][Full Text] [Related]
4. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of stannous oxidation in the preparation of ultrahigh-purity 99m Tc(V)-DMSA.
Kumar V
Nucl Med Commun; 2001 Nov; 22(11):1261-6. PubMed ID: 11606894
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
[TBL] [Abstract][Full Text] [Related]
7. Reliable preparation of 99mTc (V) DMSA by a simple modified method using a commercial kit for 99mTc (III) DMSA.
Washburn LC; Biniakiewicz DS; Maxon HR
Nucl Med Biol; 1995 Jul; 22(5):689-91. PubMed ID: 7581181
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
[TBL] [Abstract][Full Text] [Related]
10. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
Kujat C; Neidl K; Müller-Leisse C
Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
Becker W; Börner W; Reiners C
Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
16. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
17. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
[No Abstract] [Full Text] [Related]
18. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid.
Lette J; Monier D; Ledoux R; Levasseur A
Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495
[No Abstract] [Full Text] [Related]
19. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
Yen TC; King KL; Yang AH; Liu RS; Yeh SH
J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
[TBL] [Abstract][Full Text] [Related]
20. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
[No Abstract] [Full Text] [Related]
[Next] [New Search]